Temasek Holdings-backed Accuron MedTech has completed the divestment of its shares in molecular detection tests provider Veredus Laboratories to Japan-based diagnostics company SEKISUI MEDICAL, a subsidiary of SEKISUI CHEMICAL Co., Ltd.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
